IMPACT - International Meeting on Prostate Cancer Treatment is an ISP organized by ICN for Oncologists across India on New Horizons in The Management of Metastatic Prostate Cancer by using Erlamide – Apalutamide 60mg Tablet as the I.D.E.A.L start, also comparing Erlamide as combination with other therapies in metastatic castration-sensitive prostate cancer (mCSPC).
